Targeting vaccines to specific clusters of people

Hospital Pharmacy

Volumn 34, Issue 2, 1999, Pages 238-245

  Grabenstein, John D ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; VACCINE;

ASPLENIA; CANCER PATIENT; DRUG INDICATION; HOSPITAL PHARMACY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; PHARMACIST; PRACTICE GUIDELINE; REVIEW; SERODIAGNOSIS; VACCINATION;

EID: 0033496694     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857879903400210     Document Type: Review

References (35)

1. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, 1998. MMWR. 1998;47:8-12.
2. Advisory Committee on Immunization Practices. General recommendations on immunization. MMWR. 1994;43(RR-1): 1-38.
3. American College of Physicians. Guide for Adult Immunization. 3rd ed. Philadelphia, PA: American College of Physicians; 1994.
4. Grabenstein JD. ImmunoFacts: Vaccines and Immunologic Drugs. St. Louis, MO: Facts and Comparisons, Inc.; February 1999.
5. Canadian National Advisory Committee on Immunization. Canadian Immunization Guide. 4th ed. Ottawa, Ontario: Ministry of National Health and Welfare; 1993.
6. Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997.
7. Advisory Committee on Immunization Practices. Pneumococcal polysaccharide vaccine. MMWR. 1997;46(RR-8):1-24.
8. Advisory Committee on Immunization Practices. Prevention and control of influenza. MMWR. 1998;47(RR-6):1-25.
9. Advisory Committee on Immunization Practices. Immunization of health-care workers. MMWR. 1997;46(RR-18):1-42.
10. Centers for Disease Control and Prevention. Health Information for International Travel, 1996-97. Washington, DC: Government Printing Office; 1997.
11. Advisory Committee on Immunization Practices. Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR. 1993;42(RR-4):1-18.
12. Grabenstein JD. Vaccine misconceptions and inappropriate contraindications lead to preventable illness and death. Hosp Pharm. 1998;331557-1567.
13. Grabenstein JD, Hayton BD. Pharmacoepidemiologic program for identifying patients in need of vaccination. Am J Hosp Pharm. 1990;47:1774-1781.
14. Grabenstein JD. Immunization Delivery: A Complete Guide. St. Louis, MO: Facts and Comparisons, Inc.; 1997.
15. Berenguer M, Wright TL. Are HCV-infected individuals candidates for hepatitis A vaccine? Lancet. 1998;351:924-925.
16. Advisory Committee on Immunization Practices. Prevention of hepatitis A through active or passive immunization. MMWR. 1996;45(RR-15):1-30.
17. Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB, Doscher CA, Lublin FD, Knobler RL, Trantas F, Kelley L, Smith CR, LaRocca N, Lopez S. A multicenter, randomized, double-blind, placebocontrolled trial of influenza immunization in multiple sclerosis. Neurology. 1997;48:312-314.
18. Hibberd PL, Rubin RH. Approach to immunization in the immunosuppressed host. Infect Dis Clin N Amer. 1990;4: 123-142.
19. Advisory Committee on Immunization Practices. Update: Vaccine side effects, adverse reactions, contraindications, and precautions. MMWR. 1996;45(RR-12):1-35, errata 227.
20. Ambrosino DM, Molrine DC. Critical appraisal of immunization strategies for prevention of infection in the compromised host. Hemat/Oncol Clin N Amer. 1993;7:1027-1050.
21. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996.
22. Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States: Introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. MMWR. 1997;46(RR-3): 1-25, errata 183.
23. Advisory Committee on Immunization Practices. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: A joint statement by the Advisory Council for the Elimination of Tuberculosis and the ACIP. MMWR. 1996;45(RR-4):1-18.
24. Advisory Committee on Immunization Practices. Measles, mumps, and rubella - Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. MMWR. 1998;47(RR-8):1-57.
25. Advisory Committee on Immunization Practices. Prevention of varicella. MMWR. 1996;45(RR-11):1-36.
26. Cat LK, Yamauchi NK. Varicella vaccine in immunocompromised patients. Ann Pharmacother. 1996;30:181-184.
27. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics. 1996;98:196-200.
28. Pau AK, McNicholl IR, Pursell KJ. Active immunization with HIV-infectcd patients. Pharmacotherapy. 1996;16:163-170.
29. Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M, Roche K, Schwartzentruber DJ, Fox CH, Fauci AS. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. W Engl J Med. 1996;334:1222-1230.
30. Glesby W, Hoover DR, Farzadegan H, Margolick JB, Saah AJ. The effect of influenza vaccination on human immunodeficiency virus type 1 load: A randomized, double-blind, placebo-controlled study. J Infect Dis. 1996;174:1332-1336.
31. Styrt B. Infection associated with asplenia: Risks, mechanisms, and prevention. Am J Med. 1990;88(5):33N-42N.
32. Working Party on British Committee for Standards in Hacmatology/Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Brit Med J. 1996;312:430-434.
33. Advisory Committee on Immunization Practices. Control and prevention of meningococcal disease. MMWR. 1997; 46(RR-5): 1-21.
34. Siber GR, Gorham C, Martin P, Corkery JC, Schiffman G. Antibody response to retreatment immuniattion and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease. Ann Intern Med. 1986; 104: 467-475.
35. Landis S. Scarbrough ML. Using a vaccine manager to enhance in-hospital vaccine administration. J Fam Pract. 1995;41:364-369.